Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients

Author:

Chen Bojiang,Yang Lan,Zhang Rui,Gan Yuncui,Zhang Wen,Liu Dan,Chen Hong,Tang Huairong

Funder

National Natural Science Foundation of China

Department of Science and Technology, Sichuan Province, China

Health and Family Planning Commission of Sichuan province, China

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Cancer statistics in China, 2015;W Chen;CA: a cancer journal for clinicians,2016

2. European cancer mortality predictions for the year 2016 with focus on leukemias;M Malvezzi;Annals of Oncology,2016

3. Zadeh RA, Jalilian N, Sahraian MA, Kasraian Z, Noori-Daloii MR. Polymorphisms of RPS6KB1 and CD86 associates with susceptibility to multiple sclerosis in Iranian population. 2017.

4. p70 Ribosomal protein S6 kinase (Rps6kb1): an update;F Bahrami-b;Journal of clinical pathology,2014

5. Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells;RA Sinha;Autophagy,2017

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3